A Phase 3, Multi-Center, Randomized, Open Label, Paralle

Project: Research project

Project Details

Description

A Phase 3, Multi-Center, Randomized, Open Label, Parallel-Group Study of the Efficacy and Safety ofLenalidomide (Revlimid) Versus Chlorambucil as Fist Line Therapy for Previously Untreated Elderly Patients with B-Cell Chronic Lymphocytic Leukemia
StatusFinished
Effective start/end date8/18/0912/31/18

Funding

  • Celgene Corporation

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.